Improving the Chance of Success for Alzheimer’s Clinical Trials by Identifying and Mitigating the Risk of Fraudulent Practices
Suzanne B Hendrix, Patrick P O'Keefe, Jeffery Zhang, Kent Hendrix, Lixia Wang, Samuel P Dickson · 2025
Read Improving the Chance of Success for Alzheimer’s Clinical Trials by Identifying and Mitigating the Risk of Fraudulent Practices by Suzanne B Hendrix, Patrick P O'Keefe, Jeffery Zhang, Kent Hendrix, Lixia Wang, Samuel P Dickson (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11713901.txt.
Description
Suzanne Hendrix and five co-authors warn about fraud in Alzheimer's trials in a 2025 paper. Some trial sites have faked diagnosis records and outcome data, dragging down study success. Fake sites bias results downward, so honest trials can still be trusted when they succeed despite the drag.
Easy-to-forge paperwork and weak oversight by contract firms let the practice grow, above all during the pandemic. So-called professional patients pair with dishonest sites in many cases. The authors reviewed finished and running studies to estimate how many sites may be fraudulent. Requiring brain scans is one strong countermeasure they discuss. Fraud-prone sites often serve underrepresented groups, which also harms inclusion goals. The paper urges aggressive cleanup of trial networks.
Catalog record
| CREATOR | Suzanne B Hendrix, Patrick P O'Keefe, Jeffery Zhang, Kent Hendrix, Lixia Wang, Samuel P Dickson |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 3 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |